MX356258B - Agente de contraste para obtener imágenes de la perfusión miocárdica. - Google Patents

Agente de contraste para obtener imágenes de la perfusión miocárdica.

Info

Publication number
MX356258B
MX356258B MX2014007491A MX2014007491A MX356258B MX 356258 B MX356258 B MX 356258B MX 2014007491 A MX2014007491 A MX 2014007491A MX 2014007491 A MX2014007491 A MX 2014007491A MX 356258 B MX356258 B MX 356258B
Authority
MX
Mexico
Prior art keywords
myocardial perfusion
imagining
contrast agent
linked
imaging
Prior art date
Application number
MX2014007491A
Other languages
English (en)
Other versions
MX2014007491A (es
Inventor
Johansson Martin
Original Assignee
Respiratorius Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Respiratorius Ab filed Critical Respiratorius Ab
Publication of MX2014007491A publication Critical patent/MX2014007491A/es
Publication of MX356258B publication Critical patent/MX356258B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención trata sobre compuestos y métodos para obtener imágenes de la perfusión miocárdica, que comprenden administrar a un paciente un compuesto ligado a un resto para obtener imágenes, donde dicho compuesto se une a MC-1 y explorar al paciente utilizando una técnica de diagnóstico por la imagen. La invención también se refiere a kits que comprenden dicho compuesto o compuestos precursores ligados o no ligados a un resto para obtener imágenes.
MX2014007491A 2011-12-22 2012-12-18 Agente de contraste para obtener imágenes de la perfusión miocárdica. MX356258B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161579113P 2011-12-22 2011-12-22
SE1151249 2011-12-22
PCT/SE2012/051421 WO2013095273A1 (en) 2011-12-22 2012-12-18 Contrast agent for imagining myocardial perfusion

Publications (2)

Publication Number Publication Date
MX2014007491A MX2014007491A (es) 2015-02-17
MX356258B true MX356258B (es) 2018-05-16

Family

ID=48668967

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014007491A MX356258B (es) 2011-12-22 2012-12-18 Agente de contraste para obtener imágenes de la perfusión miocárdica.

Country Status (16)

Country Link
US (2) US9295738B2 (es)
EP (1) EP2793952B1 (es)
JP (1) JP6140187B2 (es)
KR (1) KR101931792B1 (es)
CN (1) CN104114191A (es)
AU (1) AU2012354223B2 (es)
BR (1) BR112014015124A2 (es)
CA (1) CA2859773C (es)
ES (1) ES2687234T3 (es)
HK (1) HK1201459A1 (es)
IL (1) IL233219A (es)
MX (1) MX356258B (es)
RU (1) RU2629840C2 (es)
SG (1) SG11201403429YA (es)
WO (1) WO2013095273A1 (es)
ZA (1) ZA201405199B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9955876B2 (en) * 2016-09-08 2018-05-01 Raul Chirife Device and method for assessment of left ventricular ejection fraction and other parameters of cardiac performance
CN107233585B (zh) * 2017-06-09 2021-01-22 四川大学华西医院 黄连素或其衍生物在制备心肌灌注显像剂中的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344702B2 (en) 2004-02-13 2008-03-18 Bristol-Myers Squibb Pharma Company Contrast agents for myocardial perfusion imaging
WO2005033079A1 (ja) * 2003-09-30 2005-04-14 Eisai Co., Ltd. ヘテロ環化合物を含有する新規な抗真菌剤
US7824659B2 (en) * 2005-08-10 2010-11-02 Lantheus Medical Imaging, Inc. Methods of making radiolabeled tracers and precursors thereof
US8415333B2 (en) * 2009-02-24 2013-04-09 Respiratorious Ab Bronchodilating diazaheteroaryls

Also Published As

Publication number Publication date
EP2793952A4 (en) 2015-09-09
EP2793952A1 (en) 2014-10-29
US20160101195A1 (en) 2016-04-14
CA2859773C (en) 2020-09-01
HK1201459A1 (en) 2015-09-04
IL233219A (en) 2016-08-31
US9687565B2 (en) 2017-06-27
CA2859773A1 (en) 2013-06-27
US20140341808A1 (en) 2014-11-20
KR101931792B1 (ko) 2019-03-13
ZA201405199B (en) 2015-12-23
KR20140107411A (ko) 2014-09-04
MX2014007491A (es) 2015-02-17
SG11201403429YA (en) 2014-07-30
RU2629840C2 (ru) 2017-09-04
EP2793952B1 (en) 2018-06-13
WO2013095273A1 (en) 2013-06-27
ES2687234T3 (es) 2018-10-24
IL233219A0 (en) 2014-08-31
AU2012354223B2 (en) 2017-03-16
JP2015500873A (ja) 2015-01-08
RU2014125849A (ru) 2016-02-10
JP6140187B2 (ja) 2017-05-31
BR112014015124A2 (pt) 2017-06-13
US9295738B2 (en) 2016-03-29
CN104114191A (zh) 2014-10-22
AU2012354223A1 (en) 2014-07-03

Similar Documents

Publication Publication Date Title
TR201904041T4 (tr) Protein agregasyonu ile bağlantılı hastalıklarda ve/veya nörodejeneratif hastalıklarda rol oynayan proteinlerin agregasyonunu inhibe etmeye yönelik ilaçlar.
GEP20237479B (en) Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
WO2009110984A3 (en) Contrast agents for applications including perfusion imaging
NZ590923A (en) Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment
NO20064011L (no) Kontrastmidler for myokardial perfusjonsbilleddannelse
TR201910084T4 (tr) Radyoaktif-etiketli prostat spesifik membran antijen inhibitörleri.
EA201491362A1 (ru) Анестезирующие соединения и способы их применения
BR112016010080A8 (pt) compostos de pirazolopirimidina, composição farmacêutica e seu uso
EA200900048A1 (ru) Новые карбонилированные (аза)циклогексаны в качестве лигандов d3 рецептора дофамина
EA201170198A1 (ru) Фармацевтические композиции, содержащие лиганды рецептора дофамина
EA201190179A1 (ru) Способы и промежуточные химические соединения для получения фармацевтических средств
TN2012000152A1 (en) Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
EA201290208A1 (ru) Способ лечения андроген-рецептор позитивных раковых заболеваний
MY183312A (en) Pharmaceutical formulation
TN2013000413A1 (en) Glycoside derivatives and their uses for the treatment of diabetes
RU2012148909A (ru) Новый синтез соединений тиазолидиндиона
PH12015500252A1 (en) Niclosamide for the treatment of solid tumors
MA35086B1 (fr) Compose de triazolopyridine
MX352546B (es) Compuesto para la union de glicoproteina iib/iiia especifica a plaquetas y su uso para la formacion de imagenes de un trombo.
EA201190293A1 (ru) Пролекарства триптолида
EA201400165A1 (ru) Частицы на основе полиакрилата, которые содержат активное соединение
EP3404029A3 (en) Pyrimido-pyridazinone compounds and methods and use thereof
EA201391524A1 (ru) Производные гликозида и их применение
MX356258B (es) Agente de contraste para obtener imágenes de la perfusión miocárdica.
JP2013540778A5 (es)

Legal Events

Date Code Title Description
FG Grant or registration